Pharmafile Logo
Pharmafocus logo
Advanced Search

Abbott raises sales expectations for Humira

January 21, 2004

Abbott Laboratories has raised its sales forecast for Humira, its new rheumatoid arthritis treatment, to $700 million in 2004 after …

News

Pfizer to sell diagnostics business

January 21, 2004

Pfizer has agreed to sell its Swedish in-vitro allergy and autoimmune diagnostic business to private equity groups Triton and PPM …

News

Aventis and Sanofi attempt to quash merger rumours

January 19, 2004

Sanofi-Synthelabo and Aventis have been forced to officially deny they are in merger talks after speculation sent shares soaring in …

News

Streamlined research

January 19, 2004

For many years the pharmaceutical industry has been promising that they were on the verge of a boom in the …

Feature

Sizing up med ed

January 19, 2004

The use of medical education in the pharmaceutical industry has never been greater. Starting from the early stages of clinical …

Feature

Too close for comfort?

January 19, 2004
Medical Communications, Sales and Marketing doctors, industry reputation

The pharmaceutical industry's increasing scale and influence means that no part of its conduct is above scrutiny, and criticism of …

Feature

Pfizer to sell-off sixty OTC products in Europe

January 16, 2004

Pfizer is looking to sell off about 60 non-core consumer products in Europe to position the business for long-term growth …

News

Eloxatin approved in US as first line treatment

January 16, 2004

Sanofi-Synthelabo's Eloxatin has received US approval for use as first line treatment of colorectal cancer in combination with standard treatment …

News

W.A.R marshals forces for healthcare push

January 16, 2004

Independent marketing communications agency Ware Anthony Rust has consolidated its healthcare accounts into a new division prompted by the sector's …

News

Genzyme to set up research facility in UK

January 16, 2004

Genzyme, one of the US' most successful biotechnology companies has chosen Cambridge as the location of its first research centre …

News

Renal care standards unveiled

January 15, 2004

News

More states defy FDA warnings on re-imports

January 15, 2004

A number of states and cities are drawing up plans to import medicines from Canada in open defiance of the …

News

GSK faces $5 billion tax claim

January 15, 2004

News

New patient forums launch recruitment drive

January 8, 2004

New bodies intended to give patients and the public a greater say in their local health service have been launched …

News

Landmark parallel trade victory for industry

January 8, 2004

News

Exanta ready for launch across Europe

January 7, 2004

AstraZeneca's new blockbuster candidate Exanta has been approved in France for the prevention of blood clots in major orthopaedic surgery.The …

News

Prescribing indicators included in PCT ratings overhaul

January 7, 2004

The  performance indicators used to calculate the star ratings of trusts in England have been given a major overhaul following …

News

Licensing delays cost SkyePharma

January 7, 2004

News

NHS to sue generic firms over price-fixing

January 7, 2004

News

Elan sells European sales and marketing business for $120 million

January 5, 2004
Elan

Debt-laden Irish pharma company Elan has sold its European sales and marketing business to Medeus – a new pharma company …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025